Humes Jennifer
SEC CIK 2058012 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | CAO | 106.4K | — | $384.1K | 6 | 2025-03-20 | 2026-09-20 |
Most active insiders at ROIV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MANCHESTER KEITH S | Dir | — | $154.47M |
| 2 | Gold Daniel Allen | Dir | — | $147.38M |
| 3 | QVT Financial LP | Dir by Deputization | — | $147.38M |
| 4 | Sukhatme Mayukh | Pres, CIO, Dir | — | $109.13M |
| 5 | Ramaswamy Vivek | 10% | — | $105.88M |
| 6 | Venker Eric | Pres, Immunovant CEO | — | $89.77M |
| 7 | Torti Frank | Pres, Vant COB | — | $82.04M |
| 8 | Gline Matthew | CEO, Dir | — | $46.17M |
| 9 | Pulik Richard | CFO | — | $9.12M |
| 10 | Fitzgerald Meghan | Dir | — | $3.27M |
| 12 | Humes Jennifer | CAO | — | $384.1K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 21:00 | 2026-09-20 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | F - Tax | $39.77 | -3,880 | 106.4K | -4% | -$154.3K | |
| 2026-06-23 21:16 | 2026-06-20 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | F - Tax | $31.43 | -3,582 | 109.8K | -3% | -$112.6K | |
| D | 2026-04-22 18:26 | 2026-04-20 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | A - Grant | $0.00 | +29.2K | 113.4K | +35% | $0 |
| 2026-04-10 18:00 | 2026-04-08 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | S - Sale | $28.37 | -13.5K | 84.2K | -14% | -$384.1K | |
| 2026-03-24 | 2026-03-20 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | F - Tax | $27.70 | -14.5K | 97.7K | -13% | -$402.4K | |
| D | 2025-03-24 | 2025-03-20 | ROIV | Roivant Sciences Ltd. | Humes Jennifer | CAO | A - Grant | $0.00 | +112.3K | 112.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations